The public 'recruitment' campaign promoting the new cervical cancer vaccine Gardasil has done little to educate adolescent girls about the cause of the cancer, University of Sydney researchers Kellie Burns and Kate Russell have found.
Dr. Burns and Dr. Russell, both lecturers in health education in the Faculty of Education and Social Work, have followed the rollout of the vaccine in two girls' schools over the last 12 months.
They found a significant lack of understanding among high school girls and their parents about the causes of cervical cancer, and that the campaign had missed an opportunity to properly inform girls about preventative sexual health.
Dr. Burns said that "the key information missing in the pamphlets and the advertising is about human papillomavirus (HPV), which causes the cancer. The girls receiving the inoculation are also ill informed about HPV's link to sexual activity or health."
The vaccine is voluntary in Australia, and while this gives individuals choice and control over their health decisions, Dr. Burns said that "choice without information is the problem."
Dr. Burns and Dr. Russell support the vaccination program, but believe young women and their parents need to have all the available information, including discussions of the possible risks and side effects, to make their decisions. Without this the effectiveness of the program's aims is compromised and the importance of ongoing cervical screening, supported by research, could be overlooked.
The study looked at the students' knowledge about the spread and nature of HPV. Dr Burns said: "The girls knew very little, but had plenty of questions; they hadn't talked much about it."
"The parents in particular were trusting the school to provide information without knowing what advice their daughters were getting.
"The schools were very supportive of the vaccine program and we found that some teachers included the HPV vaccine in their health education classes, an ideal environment for these discussions to take place in. Other teachers were less inclined to discuss it."
"What we've been getting back from principals is that there is no difference in terms of how the school is involved in the rollout with the cervical cancer vaccine compared to, for example the hepatitis B or chickenpox vaccines," Dr. Burns said. "They want to maintain the sense of normalcy around the vaccine."
"That is a positive message for normalizing a program that relates to sexual health but the negative side is that an opportunity for students to learn about HPV and its relationship, not only to cervical cancer but to broad sexual health practices, is being missed."
Explore further: New chemical technology boosts potency of targeted cancer therapy